Wei and Zhang [36] investigated the association of POR*28 polymorphisms and the lipid-lowering effects of atorvastatin (20 mg/d for 4 weeks) in 179 Chinese patients with hyperlipidemia. Here, POR is linked to hyperlipidemia.